Levetiracetam Heumann

Levetiracetam, the active ingredient in Levetiracetam Heumann, is an anticonvulsant presented as an intravenous solution for IV use. It is indicated for rapid control of partial‑onset, generalized tonic‑clonic and myoclonic seizures in both adult and pediatric patients requiring immediate therapeutic levels.

GNH USA supplies Levetiracetam Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU manufacturing standards and rigorous quality controls. The product is distributed under strict temperature‑controlled logistics to maintain stability through certified cold‑chain carriers.

Levetiracetam is an anticonvulsant used to manage seizure disorders.

Partial‑onset seizures: Reduces frequency and severity of focal seizures. Generalized tonic‑clonic seizures: Controls convulsive episodes across the brain. Myoclonic seizures: Decreases rapid muscle jerks associated with this seizure type. Adjunct therapy in refractory epilepsy: Provides additional seizure control when other agents are insufficient.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Fatigue - Dizziness - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as neutropenia or thrombocytopenia - Hepatic dysfunction - Suicidal ideation or behavior - Severe skin rash

When using Levetiracetam, consider the following precautions. - Renal impairment: Adjust dose based on creatinine clearance. - Hepatic dysfunction: Monitor liver enzymes regularly. - Psychiatric symptoms: Observe for mood changes, depression or aggression. - Pregnancy: Use only if benefit outweighs potential risk; data limited. - Concomitant CNS depressants: Use with caution as additive sedation may occur. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levetiracetam can interact with several medicines; review them before prescribing.

Major Interactions (Avoid): - Live vaccines: May reduce vaccine efficacy; avoid concurrent administration. - Carbamazepine: May decrease levetiracetam plasma levels. - Phenobarbital: May lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: Potential additive CNS depression. - Other antiepileptic drugs (e.g., valproate): May require dose adjustment. - Renal excretion inhibitors (e.g., probenecid): May increase levetiracetam levels.